Mr. Dan Matlow reports

MEDWORXX SOLUTIONS INC. ANNOUNCES SHAREHOLDER APPROVAL OF PLAN OF ARRANGEMENT

Medworxx Solutions Inc. shareholders have approved the previously announced plan of arrangement involving Medworxx and an affiliate of Aptean Inc.

At the special meeting of Medworxx shareholders held earlier today, the arrangement was approved by approximately 99.97 per cent of the votes cast by shareholders of Medworxx represented in person or by proxy at the special meeting. In accordance with Multilateral Instrument 61-101 (protection of minority securityholders in special transactions), the arrangement was also approved by approximately 99.96 per cent of the votes cast at the meeting by disinterested shareholders.

The completion of the arrangement remains subject to the approval of the Superior Court of Ontario. The hearing is to be held at 330 University Ave., eighth floor, Toronto, Ont., on Oct. 13, 2015, at or about 10 a.m. If approved and all other conditions to the arrangement are satisfied, Aptean will acquire all of the outstanding Class A common shares of Medworxx, and Medworxx will become a wholly owned subsidiary of Aptean.

The Class A common shares of Medworxx are expected to be delisted from the TSX Venture Exchange at the close of trading on or about two business days after the closing of the arrangement.

Closing of the arrangement is expected to occur on or about Oct. 14, 2015.

Further information regarding the arrangement may be found in the management information circular of Medworxx dated Sept. 9, 2015, prepared in connection with the special meeting of Medworxx shareholders and available under Medworxx's profile at SEDAR.

About Aptean

Aptean is a leading provider of industry-focused mission-critical enterprise software solutions. It builds and acquires solutions to support the evolving operational needs of its customers. Its solutions help nearly 5,000 organizations stay at the forefront of their industries by satisfying their customers and continuing to operate more efficiently. For more information, visit the Aptean website.

We seek Safe Harbor.